NSCLC harboring RET fusions positive would generally predict metastasis risk and poor prognosis caused by a mutation resulting in characteristic changes of formed cancer proteins [22] and the effect of fusion partners on RET-encoded cancer proteins [23]. This evidence concerns the gene RET and cancer.